Vicapsys Life Sciences, Inc.
VICP
$1.77
$0.5039.37%
OTC PK
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 89.60K | -- | -- | 9.40K | 53.50K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | 30.20K | 52.30K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | 102.70K |
Total Current Assets | 89.60K | -- | -- | 39.70K | 208.50K |
|
|||||
Total Current Assets | 89.60K | -- | -- | 39.70K | 208.50K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 89.60K | -- | -- | 39.70K | 208.50K |
|
|||||
Total Accounts Payable | 1.24M | 1.14M | 1.06M | 970.70K | 894.70K |
Total Accrued Expenses | 916.30K | 839.00K | 736.50K | 643.80K | 340.40K |
Short-term Debt | 578.90K | 461.90K | 462.30K | 353.90K | 307.30K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 2.74M | 2.45M | 2.26M | 1.97M | 1.54M |
|
|||||
Total Current Liabilities | 2.74M | 2.45M | 2.26M | 1.97M | 1.54M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 578.90K | 461.90K | 462.30K | 353.90K | 307.30K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.74M | 2.45M | 2.26M | 1.97M | 1.54M |
|
|||||
Common Stock & APIC | 14.41M | 14.37M | 14.37M | 14.37M | 14.37M |
Retained Earnings | -17.05M | -16.82M | -16.63M | -16.30M | -15.70M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -2.65M | -2.45M | -2.26M | -1.93M | -1.33M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.65M | -2.45M | -2.26M | -1.93M | -1.33M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.65M | -2.45M | -2.26M | -1.93M | -1.33M |
|